HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Morton J Cowan Selected Research

Elements

12/2009Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and management.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Morton J Cowan Research Topics

Disease

34Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
01/2022 - 01/2008
14Graft vs Host Disease (Graft-Versus-Host Disease)
01/2021 - 12/2002
13Primary Immunodeficiency Diseases
04/2021 - 12/2008
11Infections
01/2022 - 05/2008
6Wiskott-Aldrich Syndrome
01/2020 - 01/2009
5Chronic Granulomatous Disease
01/2022 - 01/2011
5Lymphopenia (Lymphocytopenia)
01/2018 - 05/2008
3Neoplasms (Cancer)
01/2018 - 08/2017
3Reticular dysgenesis
12/2017 - 04/2014
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2016 - 03/2009
3Leukemia
11/2016 - 03/2009
2Hypersensitivity (Allergy)
01/2022 - 02/2007
2X-Linked Combined Immunodeficiency Diseases (X Linked Severe Combined Immunodeficiency)
01/2019 - 05/2008
2Hemoglobinopathies
01/2017 - 09/2014
2Body Weight (Weight, Body)
04/2015 - 11/2013
1Cytopenia
01/2022
1Severe combined immunodeficiency due to adenosine deaminase deficiency
01/2022
1Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
01/2022
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2021
1Thrombocytopenia (Thrombopenia)
01/2020
1Thrombocytopenia 1
11/2019
1Hypoxia (Hypoxemia)
10/2018
1Common Variable Immunodeficiency
10/2018
1Avian Reticuloendotheliosis
10/2018
1Ataxia Telangiectasia (Louis Bar Syndrome)
01/2018
1Bone Marrow Failure Disorders
01/2018
1Severe combined immunodeficiency with sensitivity to ionizing radiation
01/2018
1Nijmegen Breakage Syndrome
01/2018
1Hemophilia A (Haemophilia)
02/2016
1Nephrotic Syndrome (Syndrome, Nephrotic)
02/2016
1Virus Diseases (Viral Diseases)
11/2015
1Mucopolysaccharidosis I (Hurler Syndrome)
09/2015
1Hematologic Neoplasms (Hematological Malignancy)
04/2015
1DiGeorge Syndrome (Syndrome, DiGeorge)
07/2013
1Inborn Errors Metabolism (Inborn Errors of Metabolism)
09/2012
1Measles
03/2011
1Human Influenza (Influenza)
03/2011
1Whooping Cough (Pertussis)
03/2011
1Mumps
03/2011
1beta-Thalassemia (Cooley's Anemia)
02/2011
1Communicable Diseases (Infectious Diseases)
12/2009

Drug/Important Bio-Agent (IBA)

6Busulfan (Busulfex)FDA Link
01/2022 - 11/2012
4T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2022 - 07/2013
3Adenosine DeaminaseIBA
01/2022 - 10/2018
3Immunoglobulins (Immunoglobulin)IBA
04/2021 - 07/2010
3Proteins (Proteins, Gene)FDA Link
10/2018 - 01/2009
3DNA (Deoxyribonucleic Acid)IBA
01/2018 - 05/2008
3AutoantibodiesIBA
02/2016 - 07/2010
3Alkylating AgentsIBA
01/2014 - 02/2012
2AntibodiesIBA
01/2022 - 11/2015
2AntigensIBA
04/2021 - 09/2014
2fludarabineIBA
10/2017 - 11/2012
2Peptides (Polypeptides)IBA
11/2015 - 04/2012
2Alemtuzumab (Campath)FDA Link
09/2014 - 11/2012
2VaccinesIBA
08/2014 - 07/2013
2Anti-Bacterial Agents (Antibiotics)IBA
08/2014 - 03/2011
2Ficusin (Psoralen)IBA
02/2012 - 12/2002
2HLA Antigens (Human Leukocyte Antigens)IBA
02/2011 - 03/2009
1RNA Splice SitesIBA
01/2022
1Messenger RNA (mRNA)IBA
01/2022
1GlobinsIBA
01/2022
1Intravenous Immunoglobulins (IVIG)FDA Link
04/2021
1Indicators and Reagents (Reagents)IBA
04/2021
1CD40 Ligand (CD40L)IBA
01/2019
1leniolisibIBA
10/2018
1Zinc Finger NucleasesIBA
10/2018
1Phosphatidylinositols (Phosphatidylinositol)IBA
10/2018
1Sirolimus (Rapamycin)FDA Link
10/2018
1Actin-Related Protein 2-3 Complex (Arp2 3 Complex)IBA
10/2018
1DNA Ligase ATPIBA
01/2018
1DNA Ligases (Ligases, DNA)IBA
01/2018
1Methotrexate (Mexate)FDA LinkGeneric
08/2017
1Calcineurin InhibitorsIBA
08/2017
1Biomarkers (Surrogate Marker)IBA
12/2016
1Recombinases (Recombinase)IBA
10/2016
1A-factor (Streptomyces)IBA
02/2016
1DNA-Activated Protein KinaseIBA
11/2015
1Ligases (Synthetase)IBA
11/2015
1EndonucleasesIBA
04/2015
1plerixaforFDA Link
09/2014
1EnzymesIBA
04/2014
1NADPH Oxidases (NAD(P)H oxidase)IBA
01/2011
14- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA
01/2011
1Immunoglobulin M (IgM)IBA
07/2010
1Immunoglobulin E (IgE)IBA
07/2010
1Immunoglobulin A (IgA)IBA
07/2010
1ElementsIBA
12/2009
1gamma-Globulins (gamma-Globulin)IBA
12/2009

Therapy/Procedure

26Cell Transplantation
01/2022 - 12/2008
17Hematopoietic Stem Cell Transplantation
01/2019 - 01/2008
16Transplantation
10/2018 - 12/2002
13Therapeutics
01/2022 - 10/2009
8Drug Therapy (Chemotherapy)
01/2019 - 10/2008
2Stem Cell Transplantation
04/2015 - 12/2014
1Kidney Transplantation
01/2019
1Critical Care (Surgical Intensive Care)
09/2015
1Enzyme Replacement Therapy
09/2015
1Immunotherapy
04/2015
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
02/2011
1Homologous Transplantation
09/2010